Study of pharmacokinetics of an in situ forming gel system for controlled delivery of florfenicol in pigs

Journal of Veterinary Pharmacology and Therapeutics
Z-X GengZ-G Yu

Abstract

To reduce florfenicol (FFC) administration frequency in veterinary use, the drug was currently developed into in situ forming gel. Twelve pigs were randomly divided into two groups (six pigs per group). A single i.m. dose of 40 mg/kg body weight (b.w.) was given to pigs, group one was given FFC in situ forming gel, and group two was given FFC conventional injection. High-performance liquid chromatography (HPLC) was used to determine FFC plasma concentrations. There were significant differences (P < 0.01) between FFC in situ forming gel and conventional injection, in pharmacokinetic parameters MRT (mean retention time) (57.79 ± 2.88) h versus (15.94 ± 1.29) h, AUC (area under the concentration-time curve) (421.54 ± 8.97) μg·h/mL versus (168.16 ± 4.59) μg·h/mL, tmax (time of occurrence of cmax ) (9.00 ± 2.68) h versus (4.33 ± 0.82) h, cmax (maximum plasma concentration) (6.87 ± 0.66) μg/mL versus (12.01 ± 0.66) μg/mL, t1/2λz (terminal elimination half-life) (38.04 ± 2.20) h versus (9.15 ± 2.71) h. The results demonstrated that the in situ forming gel system could shorten dosing interval of FFC and thus achieved less frequent administration during long-term treatment.

References

Nov 1, 1972·Journal of Biomedical Materials Research·I R Schmolka
Aug 1, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·A Rothen-WeinholdR Gurny
Nov 24, 1999·International Journal of Pharmaceutics·M L VeyriesB Rouveix
May 5, 2000·International Journal of Pharmaceutics·A PaavolaP Rosenberg
Dec 14, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·James G W WenzelUday B Kompella
Dec 14, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lin ZhangUday B Kompella
Nov 25, 2003·Journal of Veterinary Pharmacology and Therapeutics·J ShenJ R Coats
Aug 7, 2004·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Eve Ruel-Gariépy, Jean-Christophe Leroux
Nov 11, 2006·Pharmaceutical Research·Gilles DumortierJean Claude Chaumeil
May 8, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Diego A Chiappetta, Alejandro Sosnik
Oct 31, 2007·Pharmaceutical Research·Heiko KranzRoland Bodmeier
Aug 1, 2007·Expert Review of Respiratory Medicine·Christine K HesjeJoseph M Blondeau
Sep 16, 2010·Journal of Veterinary Pharmacology and Therapeutics·S K ChangC C Chou
Feb 22, 2011·International Journal of Pharmaceutics·Tofeeq Ur-RehmanGerhard Gröbner
Oct 17, 2012·Journal of Veterinary Pharmacology and Therapeutics·G-Y WangS-X Jiang
Nov 8, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Laleh Erfani JabarianRassoul Dinarvand
Mar 26, 2013·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Maja RadivojšaPegi Ahlin Grabnar

❮ Previous
Next ❯

Citations

Aug 1, 2015·Journal of Veterinary Pharmacology and Therapeutics·H-M LiZ-G Yu
Jun 2, 2017·Journal of Veterinary Pharmacology and Therapeutics·M R QianB Yang
Jul 6, 2018·Journal of Veterinary Pharmacology and Therapeutics·Zhichang LiuZhenling Zeng

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.